Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

The Column Group

The Column Group
VC INVESTOR TYPE
Active STATUS
11 PROFESSIONALS
64 INVESTMENTS
23 PORTFOLIO
14 EXITS
Description

The Column Group is a science-driven venture capital investment firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics. The firm was founded in 2007 and is headquartered in San Francisco, California.

Investor Status
Actively Seeking New Investments
Year Founded
2007
Primary Investor Type
Venture Capital
Primary Office
  • 1700 Owens Street
  • Suite 500
  • San Francisco, CA 94158
  • United States

+1 (415) 000-0000

The Column Group Investments (64)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
eFFECTOR Therapeutics 13-May-2019 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 00000000 00000 00.0
00000000 14-Mar-2019 00000 00000 0000 Drug Discovery Startup 0000000 0000000 00.0
0000000 0000000000 20-Feb-2019 00000 00000 00000 Pharmaceuticals Clinical Trials - Phase 2 0000000 0000000 00.0
00000 000000000000 04-Jan-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 00000 0000000000
00000000 05-Dec-2018 00000 00000 0000 Biotechnology Startup 0000000 0000000 00.0
000000 00000000000 18-May-2018 00000 00000 0000 Drug Delivery Startup 00000000 00000 00.0
0000000 0000000000 09-May-2018 00000 00000 0000 Biotechnology Pre-Clinical Trials 000000 00000 00.0
0000000000000 0000 09-Apr-2018 00000 00000 00000 Biotechnology Clinical Trials - Phase 1 00000 0000000 00.0
FLX Bio 01-Apr-2018 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 1 00000 0000000 00.0
Revolution Medicines 23-Mar-2018 Early Stage VC 0000 Biotechnology Startup 00000000 00000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore The Column Group’s full profile, request a free trial.

The Column Group Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
NGM Biopharmaceuticals 04-Apr-2019 IPO 00000 Completed
000000000 00000000 28-Sep-2018 000 00000 Completed
0000000000000 0000 19-Jul-2018 000 0000 Completed
00000 00000000000 15-Mar-2018 000 00000 Completed
0000000 0000000000 27-Oct-2017 000 00 00000000 Completed
000000 00000000000 08-Apr-2015 000000000000000000 00.000 Completed
  • 0000000-00000 0000
0000000 0000000000 27-Aug-2014 000000000000000000 00.000 Completed
  • 000000000
000000 000000 24-Jul-2014 000 0000 Completed
Cyterix Pharmaceuticals 01-Jan-2014 Bankruptcy: Liquidation Completed
Aragon Pharmaceuticals 21-Aug-2013 Merger/Acquisition 000 Completed
To view this investor’s complete exits history, request access »

The Column Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore The Column Group‘s full profile, request access.

Request full access to PitchBook

The Column Group Team (25)

Name Title Deals Funds Boards Office Contact
Info
James Evangelista Chief Financial Officer San Francisco, CA
Peter Svennilson Co-Founder & Managing Partner 00 0 0 San Francisco, CA
David Goeddel Ph.D Managing Partner 00 0 0 San Francisco, CA
Robert Tjian Ph.D Science Partner & Co-Founder 0 0 0 San Francisco, CA
Helen Kim Partner 0 San Francisco, CA

4 Former Team Members

You’re viewing 5 of 25 team members. Get the full list »

The Column Group Co-Investors (82)

Name With Exits Lead Partner
Topspin Partners 5 0 0
Altitude Life Science Ventures 0 0
EcoR1 Capital 0 0 0
NS Investment Partners 0 0
OrbiMed 0 0 0
To view this investor’s complete co-investor history, request access »